Active 1000 mg Tempol Solution for Mucositis

"While Phase 2 trials don't have the same efficacy data as later stages, our team believes that the Active 1000 mg Tempol Solution is safe enough to warrant a score of 2."

"According to the latest information available on clinicaltrials.gov, this trial is still recruiting patients. Originally posted on May 13th, 2019; the listing was most recently updated on February 2nd, 2022."

"The first study of Active 1000 mg Tempol Solution took place in 2019 at Montefiore Medical Center-Einstein Campus. As of now, there have been 9 completed studies with 4 more clinical trials underway; many of these located in Merced, California."

"There are 11 total sites for this trial, which are enrolling patients currently. These locations include Mercy Medical Center in Merced, California; University of Washington Medical Center in Seattle, Washington; and Central Coast Medical Oncology in Santa Maria, North carolina."

"Since 2019, Active 1000 mg Tempol Solution has been the subject of medical research. The first clinical trial was sponsored by Matrix Biomed, Inc. and took place in 2019. This initial study involved 120 participants. Following the successful completion of this Phase 1 trial, Active 1000 mg Tempol Solution received approval for Phase 2 trials. As of today, there are 4 active trials underway across 10 cities in 1 country."